Synthes To Pay $23 Million For Illegal Testing, Marketing Scheme
This article was originally published in The Gray Sheet
Executive Summary
Orthopedic device maker Synthes and its subsidiary Norian will pay a total of $23.2 million in criminal penalties for conducting unauthorized clinical trials of its Norian XR and Norian SRS bone cement products